GlassScriptPhysician profile
Brandon L Prendes
NPI 1528395852
$4,053.15
in general payments reported to CMS, 2019-2025
8 companies · $362 in 2025
The $362 reported for 2025 was more than what a typical Facial Plastic Surgery provider received nationally (typical 2025 total: $271).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $198 · 2022: $239 · 2023: $3,254 · 2025: $362.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $2,500 · Food and Beverage: $672 · Travel and Lodging: $444.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $2,500.00 |
| Food and Beverage | $672.14 |
| Travel and Lodging | $444.24 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $2,961.23 | 2023 | Da Vinci Sp, Da Vinci Surgical System |
| Stryker Corporation | $412.64 | 2019-2025 | Na, Vsp System, Vsp Cranial |
| Atos Medical INC | $156.20 | 2025 | Provox Life Home Hme |
| Tactile Systems Technology INC | $144.17 | 2022 | |
| Integra Lifesciences Corporation | $128.32 | 2022-2023 | Tenoglide |
| Acera Surgical, INC. | $122.86 | 2019 | |
| Medtronic, INC. | $91.67 | 2023 | Bizact |
| Baxter Healthcare | $36.06 | 2025 | Tisseel |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brandon Prendes listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.